Recommendations for the Verification of Quantitative Molecular Hemato-Oncology Tests

키워드

참고문헌 (23)

1. Heuser M, "2021 Update on MRD in acute myeloid leukemia : a consensus document from the European LeukemiaNet MRD Working Party", Blood, 138, pp.2753~2767 (2021)
2. Mazaika E, "Digital droplet PCR : CNV analysis and other applications", Curr Protoc Hum Genet, 82, pp.7.24.1~7.24.13 (2014)
3. Halling KC, "Test veriflcation and validation for molecular diagnostic assays", Arch Pathol Lab Med, 136, pp.11~13 (2012)
4. Evaluation of detection capability for clinical laboratory measurement procedures; Approved guideline—Second edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document EP17-A2 (2012)
5. "Molecular Diagnostic Assay Validation : Update to the 2009 AMP Molecular Diagnostic Assay Validation White Paper" (2014)[URL]
6. Molecular methods for clinical genetics and oncology testing; Approved guideline—Third edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document MM01-A3 (2012)
7. Quality management for molecular genetic testing; Approved guideline, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document MM20-A (2012)
8. Evaluation of linearity of quantitative measurement procedures, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI guideline EP06-Ed2 (2020)
9. User veriflcation of precision and estimation of bias; Approved guideline—Third edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document EP15-A3 (2014)
10. Deflning, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline—3rd edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI guideline EP28-A3c (2010)
11. "Standard: Establishment and veriflcation of performance speciflcations. 42 CFR § 493.1253, Oct. 1, 2015"[URL]
12. College of American Pathologists, "Molecular pathology checklist" (2021), College of American Pathologists
13. Mattocks CJ, "A standardized framework for the validation and veriflcation of clinical molecular genetic tests", Eur J Hum Genet, 18, pp.1276~1288 (2010)
14. Jennings L, "Recommended principles and practices for validating clinical molecular pathology tests", Arch Pathol Lab Med, 133, pp.743~755 (2009)
15. Hee-Jung Chung, "Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay", Annals of Laboratory Medicine, 40(1), pp.72~75 (2020), 대한진단검사의학회[DOI]
16. Broeders S, "Guidelines for validation of qualitative real-time PCR methods", Trends Food Sci Technol, 37, pp.115~126 (2014)
17. Jennings LJ, "Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease", Arch Pathol Lab Med, 136, pp.33~40 (2012)
18. Armbruster DA, "Limit of blank, limit of detection and limit of quantitation", Clin Biochem Rev, 29(Suppl 1), pp.S49~S52 (2008)
19. Shrivastava A, "Methods for the determination of limit of detection and limit of quantitation of the analytical methods", Chron Young Sci, 2, pp.21~25 (2011)
20. "Rare Mutation Detection Best Practices Guidelines"[URL]
21. Yuan D, "Droplet digital PCR for quantiflcation of PML-RARα in acute promyelocytic leukemia : a comprehensive comparison with real-time PCR", Anal Bioanal Chem, 411, pp.895~903 (2019)
22. Wolstencroft EC, "Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation", J Mol Diagn, 9, pp.42~46 (2007)
23. Schnittger S, "Development and validation of a real-time quantiflcation assay to detect and monitor BRAFV600E mutations in hairy cell leukemia", Blood, 119, pp.3151~3154 (2012)

관련 논문AI추천